BMSCs improve TNBS-induced colitis in rats by inducing Treg differentiation by expressing PD-L1

OBJECTIVES: Bone marrow-derived mesenchymal stem cells (BMSCs) show promise in treating inflammatory bowel disease. We tested if BMSCs improve Trinitro-benzene-sulfonic acid (TNBS)-induced colitis by inducing Treg differentiation by modulating programmed cell death 1 ligand 1(PD-L1). RESULTS: BMSCs...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Fei, Cui, Dandan, Zuo, Dongmei, Shou, Zhexing, Yang, Jia, Yu, Ting, Liu, Yujin, Chu, Si, Zhu, Feng, Wei, Chunzhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659505/
https://www.ncbi.nlm.nih.gov/pubmed/36261682
http://dx.doi.org/10.1007/s10529-022-03307-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659505/
https://www.ncbi.nlm.nih.gov/pubmed/36261682
http://dx.doi.org/10.1007/s10529-022-03307-1

Ejemplares similares